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    AIM AND OBJECTIVES           
To study the effect of tight glycaemic control on posy-operative infection in diabetics 
with raised glycosylated haemoglobin
1. To measure the incidence of post-operative infection in diabetics and to analyze its 
correlation with the level of glycosylated haemoglobin. (clinical audit)
2. To compare the effect of restricting the post-operative blood glucose < 140 mg.dL-1 
to the existing practice of maintaining it < 200 mg.dL-1 on post-operative infection, 
in diabetics with glycosylated haemoglobin more than 7%. (interventional clinical 
trial)
INTRODUCTION
Patients with diabetes mellitus have been shown to have a higher incidence of peri-
operative  morbidity  and  mortality  compared  to  those  without  diabetes,  which  is 
attributed to hyperglycaemia. (1, 2) There is substantial evidence to suggest that mean 
blood glucose levels >200-230 mg.dL-1 is associated with increased risk of infection. (1, 
3,  4)  The  widely  followed  practice  is  to  maintain  the  plasma  glucose  below  200 
mg.dL-1, in the post-operative period. (1)  However, has been shown that ‘tight’ control 
of blood sugar at 80-110 mg.dL-1 reduces the morbidity and mortality further, but this 
was achieved in an intensive care unit setting, and required frequent monitoring of blood 
sugar level to avoid hypoglycemia. (5)
Some  authors  have  suggested  that  the  effect  of  chronic  hyperglycaemia  may  also 
contribute to post-operative morbidity. (1, 6, 7) The level of glycosylated haemoglobin 
(HbA1c) reflects the control of blood glucose in the previous 8-12 weeks. (8) A clinical 
audit of 490 diabetics undergoing elective surgery demonstrated that those with HbA1c 
greater than 7% had a higher incidence of surgical site infection. (9)
This study is an effort to answer the question, whether maintaining a tighter control of 
blood  sugar  in  the  immediate  post-operative  period,  in  patients  with HbA1c > 7%, 
reduces post-operative infection.
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                                        REVIEW OF LITERATURE
Diabetes mellitus:
Diabetes mellitus is a disease characterized by hyperglycemia resulting from either a 
deficiency of insulin or resistance to its action. According to the American Diabetes 
Association  (ADA),  the  criteria  for  the  diagnosis  of  diabetes  are  the  presence  of 
symptoms of diabetes such as polyuria, polydipsia and unexplained weight loss along 
with a casual plasma glucose more than 200 mg.dL-1 (11.1 mmol.L-1); or a plasma 
glucose more than 126 mg.dl-1 (7.0 mmol.L-1) after a period of no caloric intake for 8 
hours. (10)  The ADA defines good glycaemic control as  pre-prandial plasma glucose 
between 90–130 mg.dL-1, post-prandial plasma glucose less than 180 mg.dL-1 and a 
glycosylated  haemoglobin  (HbA1c)  level  less  than  7%.  These  levels  are  also 
recommended for patients admitted in the hospital. (10, 11)
Diabetics are at increased risk for premature morbidity and mortality associated with 
vascular,  renal,  retinal,  and  neuropathic  complications  due  to  long  standing 
hyperglycaemia.  (12,  13)  Hyperglycaemia  is  also  associated  with  short-term 
complications such as ketoacidosis and hyperosmolar coma, intracellular dehydration, 
electrolyte  imbalance  (decreased  sodium,  potassium  and  phosphorous),  decreased 
phagocytosis and delayed immunologic and 
                                                 
lymphocytic activity. (14, 15)
Diabetes and Surgery:
A diabetic patient is said to have 25 % chance of undergoing surgery during his lifetime. 
This is due to the increase in the incidence of atherosclerosis and related complications 
like  ischemic  heart  disease,  peripheral  vascular  disease  along  with  micro  vascular 
complications leading to retinopathy, neuropathy, and nephropathy. (16)
The  incidence  of  peri-operative  morbidity  and  mortality  among  diabetic  patients  is 
higher  when compared to  non-diabetics,(17,18)  but  better  monitoring and control  of 
peri-operative blood glucose have shown a decline.(20,29 ) During peri-operative period 
the  goal  is  to  maintain  the  plasma  glucose  levels  that  minimize  the  risk  for 
hypoglycemia but that are low enough to prevent post-operative morbidity. 
The various recommendations for the ideal level of plasma glucose, during the peri-
operative period are 120-200 mg.dL-1 (19,20,21,22,23), 125-180 mg.dL-1, < 150mg.dL 
-1 (8.3mmol.L-1) following cardiac surgery (1) and the most recent being to aim as 
close to 110 mg.dL-1 in a critical care unit (5,10) and 90-130 mg.dL-1 in a general ward. 
(10, 11) Most authors would agree that glucose level should be maintained below 200 
mg.dL-1.
There is evidence to suggest that in-hospital hyperglycemia is associated with adverse 
outcomes.  A meta-analysis of 14 studies has shown that hyperglycemia (blood glucose 
>140 mg.dL-1) with or without a prior diagnosis of diabetes increased both in-hospital 
mortality and congestive heart failure (CHF) in patients admitted for acute myocardial 
infarction (2).
Similar  data  were  reported  in  a  prospective  study  of  336  patients.  Hyperglycemia 
(fasting blood glucose >126 mg.dL-1, random blood glucose >200 mg.dL-1  in general 
medical  and  surgical  units  was  associated  with  an  18-fold  increase  in  in-hospital 
mortality, a longer length of stay , more subsequent nursing home care, and a greater 
risk of infection (3) .
Diabetes and Surgical site infection:
A diabetic patient is at  greater risk during the post-operative period to systemic and 
surgical  site infection and they are also prone to metabolic decompensation, such as 
fluctuating blood glucose levels and keto-acidosis. (1, 14, 24) The association between 
hyperglycemia and the susceptibility to surgical site infection is multi-factorial.
i) Hyperglycemia has been shown to impair the normal functions of the neutrophils, 
which  include  adherence,  chemotaxis,  phagocytosis  and  intracellular  bactericidal 
activity.  The  degree  of  neutrophil  impairment  correlates  with  the  degree  of 
hyperglycemia. The glucose level threshold for neutrophil dysfunction is 200 mg.dL-1 
(range - 130-275 mg.dL-1). (1) 
ii) Hyperglycemia alters vascular permeability and the normal redox reactions which 
creates a state of pseudo-hypoxia and impaired tissue defenses. Elevated tissue levels of 
glucose  and  the  formation  of  oedema  due  to  the  increased  vascular  permeability, 
promotes bacterial growth. (1)
iii)  Micro-  and  macro-vascular  manifestations  of  diabetes  may  disrupt  supply  of 
nutrients,  oxygen, leukocytes and antibiotics to the operated site leading to impaired 
wound  healing.  (1)  Oxygen  is  necessary  for  macrophage  mobility  and  growth  of 
granulation tissue. 
iv) In patients with diabetic neuropathy, disruption of the skin may go undetected which 
can form a portal for entry of the bacteria. (1) 
v) Glucose is a pro-inflammatory mediator that has been shown to stimulate cytokine 
production and inhibit  endothelial  nitric oxide levels.  Insulin enhances the ability of 
cytotoxic lymphocytes to attack target cells. (1) Therefore, insulin deficiency makes the 
diabetic patients more susceptible to infection.
vi) The bone marrow-derived endothelial progenitor cell is vital in vasculogenesis and 
wound healing, but their numbers are decreased in diabetes due to impaired activity of 
endothelial derived nitric oxide synthetase. (25, 26, 27) Poor healing of diabetic wounds 
is characterized by impaired angiogenesis and vasculogenesis. Control of blood sugar 
level also retards the progression of vascular complications.
Latham et al (6) studied the association of glucose control with surgical site infections 
among patients undergoing cardio-thoracic surgery. In a prospective cohort and case-
control study, to assess the importance of diabetes, diabetes control, hyperglycemia, and 
previously undiagnosed diabetes  in the development of  surgical-site infections.  They 
found that presence of diabetes and post-operative hyperglycaemia were independently 
associated with development of surgical site infection.
Rossini et al (14) reviewed various studies suggesting a relationship between metabolic 
abnormality  and  the  diabetic  complications.  They  divided  the  complications  of 
uncontrolled diabetes into two major categories – short term and long term. The short 
term complications are ketoacidosis with hyperosmolar coma, intracellular dehydration, 
electrolyte imbalance,  decreased phagocytosis,  reduced immunologic and lymphocyte 
activity, and impaired wound healing. The long term complications are nephropathy, 
neuropathy,  retinopathy,  cataract  formation,  perinatal  mortality  and  those  due  to 
vascular disease. They suggested that until the question of degree of control of diabetes 
can absolutely be resolved, the recommendation should be that the blood glucose level 
be controlled as close to the normal as possible.
Stephen H, et al (13) did a retrospective cohort study to determine the impact of diabetes 
mellitus on short-term mortality and morbidity in patients undergoing coronary artery 
bypass surgery. They found that the 30-day mortality was 3.7% in patients with diabetes 
and 2.7% in those without. Morbidity, infections and the composite outcomes occurred 
more commonly in diabetic patients and were associated with a risk about 35% higher in 
diabetics than in non-diabetics. They concluded that diabetes is an important risk factor 
for mortality and morbidity among those undergoing coronary artery bypass surgery. 
They concluded that  more research was needed to determine if  better  peri-operative 
glycaemic control improved outcome.
Bhatia  et al (28) did a prospective study to evaluate the risk factors for postoperative 
wound infection in 615 patients  undergoing coronary artery bypass graft  surgery,  of 
whom  269  (43%)  were  diabetic.  116  (18.86%)  patients  developed  infection  of  the 
surgical sites involving sternum (75%), leg (21.3%) and forearm (3.44%).  Sternal site, 
obesity, diabetes mellitus and female gender were associated with significantly higher 
infection rates. Diabetes, especially uncontrolled, was a significant risk factor for the 
development of surgical site infection. 
Golden et al (1) studied the peri-operative glycaemic control and the risk of infections 
complications in 411 diabetics,  who underwent coronary artery surgery. Peri-operative 
glycaemic control was assessed by the average of six capillary glucose measurements 
taken during the 36 hour following surgery. The major outcomes studied were infections 
of the leg and the chest wounds, pneumonia and urinary tract infection. They found that 
patients  with  higher  mean  capillary  glucose  readings  were  at  increased  risk  of 
developing infections compared with those with the low post-operative glucose levels. 
They concluded that in diabetics who undergo coronary artery surgery, hyperglycemia is 
an independent predictor of short-term infections in the post-operative period, and the 
physician should consider a glucose concentration target of <200 mg.dL-1 to reduce the 
risk of infection. 
Glycaemic control in immediate post-operative period:
Zerr  et  al (4)  investigated  the  occurrence  of  wound  infection  in  a  cohort  of  1,585 
diabetics  who  underwent  cardiac  surgery.  There  was  a  strong  correlation  of  risk  of 
wound infection with the mean concentration of blood glucose on the first postoperative 
day.  It  increased  from  1.3%  among  patients  with  glucose  level  between  100-150 
mg.dL-1, to 6.7% among those with levels of 250-300 mg.dL-1.
McAlister et  al (29) studied 291 diabetic patients undergoing coronary artery bypass 
graft  surgery,  to  explore  the  association  between  glycaemic  control  and  in-hospital 
morbidity and mortality. They found that  hyperglycaemia > 200 mg.dL-1, on the first 
post-operative day, was associated with adverse outcome.
Gandhi  et al (30) conducted a retrospective observational study of consecutive adult 
patients  who  underwent  cardiac  surgery  to  estimate  the  magnitude  of  association 
between intra-operative hyperglycemia and peri-operative outcome. They concluded that 
intra-operative hyperglycemia is an independent risk factor for complications, including 
death, after cardiac surgery.
Hyperglycemia  is  an  independent  predictor  of  infection  in  patients  with  diabetes 
undergoing cardiac  surgery.  (1,24) Furthermore,  hyperglycemia  in  the  first  48  post-
operative hours was associated with a  two-fold higher  rate  of  surgical  site  infection 
among  patients  undergoing  cardiothoracic  surgery  compared  with  those  who  were 
normoglycaemic. (6)
Kim et al did a retrospective study on 329 diabetic patients who had undergone lumbar 
spine surgery. Of these 152 had undergone the surgery before the implementation of a 
protocol wherein an infusion of insulin was used during the peri-operative period to 
maintain the blood glucose below 200 mg.dL-1. They demonstrated that the deep wound 
infection was significantly lower in patients who were operated after the initiation of the 
protocol to control the blood glucose level in the immediate post-operative period.  (7) 
Glycaemic control in critically ill:
Many interventional studies have linked reversal of hyperglycaemia to better clinical 
outcomes  in  medical  and  surgical  situations,  especially  following  acute  myocardial 
infarction, cardiac surgery and in critically ill patients. (36)
In a study of critically ill, medical-surgical intensive care unit patients, the use of insulin 
therapy to achieve blood glucose levels of 80–110 mg.dL-1, reduced mortality by 34%, 
sepsis by 46%, renal failure requiring dialysis by 41%, blood transfusion by 50% and 
critical illness poly neuropathy by 44% . Van den Berghe et al demonstrated that strict 
post-operative  blood  glucose  control  not  only  reduced  morbidity,  but  also  reduced 
mortality by as much as 42%. (5)
Krinsley  et  al (32)  evaluated  the  effect  of  administering  insulin  infusion  for  better 
glycaemic control  on patients admitted to a medical-surgical  ICU and compared the 
outcome with a historical control group. The study group had improved blood glucose 
levels (130.7 vs. 152.3 mg/dl) and significant reduction in mortality and median length 
of ICU stay. (32)
A meta-analysis of clinical trials evaluating the effect of insulin therapy on mortality in 
hospitalized patients with critical  illness showed that insulin therapy decreased short 
term mortality by 15% in a variety of clinical settings. (33)
Insulin and glycaemic control:
The  advent  of  insulin  revolutionalised  the  treatment(35,36,37)  of  diabetic  patients 
undergoing surgery. The mortality of diabetics undergoing foot amputations was 50% in 
the 1930’s, 32.8% in the 1940’s, 22% in the 1950’s, 9% in the 1970’s and today it is no 
different from non-diabetics undergoing the same procedure. (34) 
Rassias  et  al  (35)  tested  the  effect  of  an  insulin  infusion  on neutrophil  function  in 
diabetic  patients  scheduled  for  coronary  artery  bypass  surgery  and  found  that  a 
continuous  insulin  infusion  and  glucose  control  during  surgery  improved  white  cell 
function and may increase resistance to infection after surgery. 
Lazer  et al (36) did a study to determine whether tight glycaemic control in diabetic 
coronary  artery  bypass  graft  patients  would  improve  peri-operative  outcome. One 
hundred  forty-one  diabetic  patients  undergoing  cardiac  surgery  were  prospectively 
randomized to either tight glycaemic control (125 - 200 mg.dL-1) or standard control 
(250 mg.dL-1) using intermittent subcutaneous insulin before induction of anaesthesia 
and continuing for 12 hours after surgery. Patients in the tight glycaemic control group 
had a lower glucose level 
(138 mg.dL-1 versus 260 mg.dL-1), a lower incidence of atrial fibrillation (16.6% versus 
42 %) and a shorter post-operative length of stay (6.5 versus 9.2 days). Patients with 
tight  glycaemic  control  also  showed  a  higher  survival  over  the  initial  2  years  after 
surgery with decreased episodes of recurrent ischemia (5 % versus 19 %) and had fewer 
episodes of wound infections.
Furnary et al (4) compared the impact administering insulin by continuous infusion to 
the  previous  practice  of  intermittent  subcutaneous  injections  in  diabetics  undergoing 
cardiac surgery. Insulin infusion during the peri-operative period reduced the risk of 
deep sternal wound infection by 57%.
Glycosylated Haemoglobin:
Glycosylated haemoglobin (HbA1c) is a term used to describe a series of stable minor 
hemoglobin  components  formed slowly  from haemoglobin  and glucose.  The  rate  of 
formation of HbA1c is directly proportional to the glucose concentration (38). Since 
erythrocytes, with a life-span of 120 days, are freely permeable to glucose, the level of 
HbA1c in a blood sample provides a glycaemic history of the previous 2-3 months. 
Laboratory measurement of HbA1c became available in the late 1970s.
HbA1c is formed non-enzymatically by haemoglobin's exposure to plasma glucose. This 
simple reaction proceeds in two stages (Fig 1). 
1. Glucose combines with the amino group of the valine residue at the N-terminus of 18 
goblin chains to form an aldimine compound (Schiff base). This reaction is reversible, 
and dissociation back to haemoglobin and glucose can occur readily.
 2. Internal rearrangement of the aldimine intermediate by the amadori reaction yields a 
stable ketoamine derivative, which is irreversible.
Glycosylation begins during erythropoiesis and continues slowly throughout the lifespan 
of the circulating haemoglobin.
As  each  erythrocyte  circulates  for  120  days,  there  is  opportunity  for  late  maillard 
reactions  or  non-enzymatic  browning  to  occur  (the  products  of  these  reactions  are 
referred to as Advanced Glycation Endproducts [AGE]) and the extent of these changes 
appear  to  correlate  with  the  level  of  HbA1c.  In  connective  tissues  and  vascular 
endothelium, AGEs may be important mediators of diabetes pathology as well as the 
normal aging process. AGE accumulate in diabetes as a result of hyperglycemia, leading 
to glycosylation of collagen. This process results in abnormal collagen, which is highly 
inflexible and prone to breakdown, particularly over pressure areas. Research has shown 
that  several  biochemical  pathways associated  with hyperglycemia,  including glucose 
auto-oxidation, polyol pathway, prostanial synthesis, and protein glycation can increase 
the  production  of  free  radicals.  (39)  Free  radicals  generated  by  the  auto-oxidation 
reactions of sugar and sugar attached to protein are possible sources of oxidation stress 
and damage to protein in patients with diabetes. Glyco-oxidation products accumulate in 
collagen at an accelerated rate in patients with diabetes. (40) This oxidative stress leads 
to complications in diabetes, such as tissue damage and cell death, which are reversed by 
antioxidants.  Anti-oxidants such as vitamin C and E can lower HbA1c levels, possibly 
by  inhibiting  glycation.  Renal  and  hepatic  diseases,  haemolytic  anemia  and 
haemoglobinopathies shorten red cell survival and therefore the period of exposure to 
glucose, leading to a decrease in HbA1c.   
Hennesse  et  al  (41) investigated the interaction of blood glucose concentration and 
wound collagen glycosylation, collagen content, and proteolytic activity during wound 
healing  in  diabetic  rats.  They  showed  that  long  term  hyperglycemia  leads  to  the 
formation of AGE, which contributes to many of the complications of diabetes.  The 
amount of AGE is proportional to the duration of diabetes. AGE leads to abnormal cross 
linking causing increased phagocytosis of the affected proteins and protein catabolism. 
This  increased  catabolism of  structurally  abnormal  proteins  in  uncontrolled  diabetic 
patients leads to impairment of wound healing.
One percent increase in glycosylated haemoglobin has been shown to be associated with 
18% increase in the risk for coronary heart disease or stroke and a 28% increase in the 
risk  for  peripheral  vascular  disease.  (42)  These  data  highlight  the  utility  of  the 
glycosylated haemoglobin level as a measure of risk for cardiovascular events in type 2 
diabetes.
Khaw et al (43) correlated the level of HbA1c to the incidence of cardiovascular events. 
They demonstrated a 21% increase in cardiovascular events for every 1% increase in 
HbA1c level  above 5%. They also concluded that  HbA1c level  of  6.59% in a  non-
diabetic predicts a higher cardiovascular risk than a HbA1c level of 5.5% in a well-
controlled diabetic. These two studies (42, 43) have clearly proved that the glycosylated 
haemoglobin level is an independent risk factor for cardiovascular events, regardless of 
diabetes status.
Bishop  et al(46) examined the effect of HbA1c level on surgical  site  infection in 32 
diabetic patients undergoing penile prosthetics surgery and found that the incidence of 
infection was higher in those with a HbA1c  > 11.5%. However, few years later, these 
observations  were  refuted  by  Wilson  et  al (47)  who  studied  114  diabetic  patients 
undergoing penile  prosthetic  surgery.  They compared wound infection in  those with 
HbA1c greater and less than 11.5% and did not find any correlation between HbA1c and 
surgical site infection.
Latham  et  al  (6)  analyzed  300  diabetic  patients  undergoing  cardiac  surgery  and 
compared  wound  infection  in  patients  with  HbA1c greater  and  less  than  8%.  They 
concluded that elevated HbA1c was not associated with statistically significant increase 
risk of infection. However, the poorly controlled diabetics had significantly higher levels 
of blood glucose in the post-operative period.
Dronge et al (9) did a retrospective observational study on the relationship of long-term 
glycaemic control and pos t-operative infection in 490 diabetics. Oral treatment was the 
main form of diabetic therapy (59.0%). The HbA1c levels ranged from 4.6% to 15.5% 
(median - 7.3%). The incidence of infection in patients with HbA1c <7% was 12% while 
it was 20% in those with Hba1c > 7%. They concluded that good pre-operative glycaemic 
control  (HbA1c below  7%)  reduces  post-operative  infections  following  a  variety  of 
surgical procedures.
Pilot Study (A Clinical Audit)
All diabetic patients scheduled for major elective surgery over a period of six months 
were included in the audit. The patients were followed up till time of discharge.
The following were recorded:
1. Glycosylated hemoglobin levels
2. Blood glucose levels (pre-, intra-, and post- operative)
3. Surgical wound site and other systemic infections
4. Metabolic derangements such as hypoglycemia and ketoacidosis 
5. Duration of hospital stay
A total of 50 patients were included in the audit over the six month period. They were 
grouped into those with HbA1c more than or less than 7%. Those with HbA1c <7% had a 
better glycaemic control before, during and after the surgery. Those with HbA1c >7% had 
wider fluctuations in glucose levels.  The incidence of wound infection in those with 
HbA1c >7% was  30% which was significantly  (p- 0.023)  higher  than in  those  with 
HbA1c <7%. The duration of hospital  stay was also significantly more in the higher 
glycosylated haemoglobin group.
Table1. Comparison between two groups:
HbA1c  > 7% HbA1c < 7% P value
Number 30 20
Age  (years) 53.2 ± 11.9 55.2 ± 10.7 0.502
Weight(kg) 62.1 ± 11.4 64.7 ± 15.8 0.493
HbA1c (%) 8.6 ± 1.47 6.3 ± 0.41 0.000 *
Preoperative sugars 164.4 ± 44.5 119.5 ± 31.3 0.000 *
Intra-operative sugars 144.7 ± 36.9 127.7 ± 18.6 0.005 *
Post-operative sugars
Day 1 238 ± 82.9 178 ± 55.1 0.0009*
Day2 228 ± 60.9 171 ± 80.8 0.0004*
Day 3 237 ± 86.9 174 ± 80.6 0.000*
Day 4 225 ± 54.0 174 ± 70.6 0.0002*
Day 5 182 ± 67.9 176 ±41.4 0.0685*
DAY 6 201 ± 56.8 147 ± 53.8 0.0000*
Complications
Wound infection 9 1 0.023*
Hypoglycemic attacks 10 3 0.004
Myocardial infarction 0 1 0.312
Hospital stay 6.9  ± 5.12 5.5  ± 1.76 0.048
                      
The patients were regrouped into those who developed wound infections in the post-
operative period and those who did not, and the data was reanalyzed. Those with wound 
infection had a higher level of HbA1c and blood glucose in the post-operative period. 
(Table 2)
Table2. Regrouped based on postoperative wound infection:
Wound infection
Without wound infection
P value
Number
10
40
Pre-operative sugars ( mg.dL-1)
163 ± 51
146 ± 38.0
0.0275
Intra-operative sugars(mg.dL-1)
140 ± 46.4
140 ± 25.2
0.54
Post-operative sugars (mg.dL-1)
The question which remained unanswered was whether tighter glycaemic control 
in the post-operative period would reduce the incidence of infection in those with 
HbA1c > 7%.
                                     
Patients and Methodology
                         
Approval  was  obtained from the  institutional  research  and ethical  committee  before 
starting the clinical trial. All diabetic patients, with glycosylated haemoglobin (HbA1c) 
of more than 7%, scheduled for elective surgery, were eligible to be enrolled in this 
study. Patients with preoperative infection were excluded. These patients were explained 
about the study by the anaesthesiologist the evening before the surgery and a written 
consent was obtained from the volunteers.
All  medications,  including  oral  hypoglycemic  drugs  (except  for  metformin)  were 
administered the evening before the surgery. The patients were fasted for six hours prior 
to surgery and allowed clear fluids up to two hours before surgery. On the day of the 
surgery,  oral  hypoglycaemic  drugs  and  insulin  were  omitted.  Blood  glucose  was 
measured just before induction of anaesthesia.
All  the  patients  received a  standard  general  anaesthetic  technique  using  midazolam, 
fentanyl,  thiopentone,  and vecuronium for  induction,  and maintained with morphine, 
oxygen, air and isoflurane.
Intra-operative Glycaemic Control:
During the intra-operative period the blood glucose was measured every hour by ‘Accu-
chek’ glucometer. The aim was to maintain the blood glucose below 140 mg.dL-1. An 
infusion of insulin (actrapid ®) in a concentration of 1 unit per ml was administered 
depending on the measured blood glucose. (Table 3) 
Table 3:  Variable Insulin Regimen:
 BLOOD 
GLUCOSE
                                    INSULIN INFUSION
  <70mg.dL-1   Stop insulin. Give 100ml of 5% dextrose Over 10min. Do 
blood glucose after 15 min  
  70 -100mg.dL-1 stop insulin and do blood glucose after 30 min  
100 – 150mg.dL-1 Insulin infusion 1 unit.hr-1. Do blood glucose after1 hr
150 – 200mg.dL-1 Give  one  unit  bolus  and  start  infusion  2units.hr-1.  Do 
blood glucose  after 1hr
200 – 250 mg.dL-1 Give 2 units  bolus and infusion 3 units.hr-1.  Do blood 
glucose after 1hrs.
250- 300mg.dL-1 3units bolus and 4 units.hr-1 .Do blood glucose after 1hrs. 
300 - 350mg.dL-1 Give 4 units bolus and start infusion 4units.hr-1. Do blood 
glucose after 1 hr     
350 – 400 mg.dL-1 Give 4 units bolus and start an infusion 5 units.hr-1 .Do 
blood glucose after 1hr 
       
At the end of the surgery, the patient was allocated into one of the following groups, 
based on a randomization table, for management of blood glucose in the post-operative 
period.
Group A – Tight Glycaemic control (<140 mg.dL-1)
Group B – Standard Glycaemic control (<200 mg.dL-1)
Blood glucose monitoring and management of the patients in group B was done by the 
respective surgical unit doctors, as per the current standard of care, in the institution, for 
diabetic patients in the post-operative period. All these patients were administered 5% 
dextrose at the rate of 100ml per hour with 5-8 units of neutral  insulin (Actrapid®) 
added to each pint. The aim was to maintain the blood glucose below 200mg.dL-1. If the 
blood  glucose  exceeded  200mg.dL-1, 6  units  of  Actrapid® were  injected 
subcutaneously. The blood glucose was monitored every 4 – 6 hours.
The management  of  those in  Group A was as  follows.  Five units  of  neutral  insulin 
(actrapid®) were added to each pint of 5% dextrose and infused at 100 ml per hour. An 
infusion of neutral insulin (actrapid®) as was started during the surgery, was continued 
during the postoperative period to maintain a blood glucose < 140 mg.dL-1. Insulin 
infusion rate was titrated as per the variable 
insulin  regime (Table  3)  according to the blood glucose level,  which was measured 
every 2 hours. This mode of management was maintained for three postoperative days or 
till the patients started normal diet. During this period, the investigator was available on 
call and could be paged for any queries or problems. 
The  patients  were  followed  up  till  the  day  of  discharge  from  the  hospital.  Any 
complications  during  this  period,  such  as  surgical  wound  infection,  re-explorations, 
fever, signs of respiratory or urinary tract infections, or sepsis were closely observed for 
and recorded. The duration of hospital stay was noted. The primary physician was asked 
to report if the patient returns within a month with signs of infection.
Wound infection was defined as the presence of sero-sanguinous or purulent discharge 
from the surgical site or wound dehiscence.
Sepsis  was  defined  as  temperature  more  than  370C  with  associated  tachycardia, 
tachypnoea and a positive blood culture. Urinary tract infection was considered if the 
patient had fever, dysuria and a growth >1,00,000 .ml-1 of bacterial colonies on urine 
culture. Blood glucose below 60 mg.dL-1 was documented as hypoglycaemia. Proforma 
is shown as Appendix.
SAMPLE SIZE  
The Clinical Audit demonstrated that the incidence of post-operative wound infection in 
diabetic patients with HbA1c level > 7% was 30% (P1). The hypothesis of the clinical 
trial was to show if maintaining the post-operative glucose level below 140 mg.dL-1 
would reduce wound infection to less than 5%.
                   
                                                             2PQ {Z1 − α∕2+ Z1-ß} 2
                         N           =                     ――――――――――
                                                                       (P1−P2)2
                      
                                                         P1+P2         30+5          35
                       P             =                ——— =   ―――   =  -— =   17.5
                                                             2                 2                2
                       Q          =             100- 17.5 = 82.5
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                                                 P1 – P2     =   30 – 5 = 25   
              
                                               2 × 17.5 × 82.5 {1.96+0.84}2  
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                                                               625                             
                                                                                         
                                             
                                                    19894
                          N     =          ——————                 =     36    
                                                     625
                                                                          
Statistical Analysis:
The  basic  structure  of  the  analysis  was  a  comparison  of  two  groups  of  patients 
undergoing  major  elective  surgery  with  high  glycosylated  haemoglobin.  The  major 
outcome event was the blood glucose control during the post-operative period and the 
development  of  surgical  wound infection.  Using the summary statistic  approach,  the 
average value of the blood glucose was calculated for each patient. Independent test was 
performed over  the summary statistic  to  find  the difference  in  mean.  Base  line and 
postoperative outcome variables were compared with the use of Pearson’s chi-square 
test. The analysis was done using ‘SPSS for Windows’ version11 software.
 
   
                       
                                               RESULTS
Fifty diabetic patients with glycosylated haemoglobin greater than 7%, scheduled for 
elective  surgery,  were  consented  for  the  study.  The  preoperative  and intra-operative 
management  of  all  the  patients  were  similar.  At  the  end  of  the  surgery,  they  were 
randomly allocated into one of the two groups to decide the glycaemic control during the 
post-operative period. The plasma glucose level of those in the Study Group was aimed 
below  140  mg.dL-1,  while  for  those  in  the  Control  Group  was  aimed  below  200 
mg.dL-1, as is the standard practice in this institution. All the patients were managed in 
the general ward.
Demographic Data: 
The patients in both the groups were comparable with respect to age, weight, duration of 
diabetes, level of HbA1c, and the fasting blood glucose on the day of surgery (Table 4).
Glycaemic control:
During the intra-operative period, the blood glucose was measured every hour for all the 
patients while during the post-operative period, it was measured every 2 hours for those 
in the Study Group and every 4 - 6 hours for those in the Control Group. The mean 
blood glucose during the intra-operative period and for  each post-operative day was 
calculated for each patient, and compared between the groups (Table 5). There was no 
statistically significant difference between the preoperative and the intra-operative blood 
glucose between the two groups. However, the blood glucose was significantly higher in 
the Control Group on the first five post-operative days.
Morbidity and Mortality:
Table 6 shows the comparison of morbidity and mortality in the study and the control 
group. Thirteen (44%) patients in the ‘Control’ group developed infection compared to 
only one (4%) in the ‘Study’ group. In the ‘Control’ group, 7 (28%) patients developed 
wound infection while only 1 (4%) patient in the ‘Study’ group had wound infection. 
This was statistically significant (p-0.023). The incidence of respiratory tract infection 
was also higher in the ‘Control’ group. 
The  incidences  of  hypoglycemic  episodes  were  comparable  in  the  two  groups.  The 
hospital stay was prolonged in the’ Control’ group (10.5 days) compared to the ‘Study’ 
group (8 days), but it is not statistically significant. One patient in the study group died 
due to leakage from the bowel anastomosis leading to sepsis.
Factors affecting Wound Infection:
The  characteristics  of  those  patients  who  developed  surgical  site  infection  were 
compared with those who did not (Table 7). The blood glucose levels were significantly 
higher during the surgery and during the first three post-operative days, in those who 
had  surgical  site  infection.  The  duration  of  diabetes  was  longer  in  those  who  had 
infection, although not statistically significant. Patients with surgical site infection had a 
longer hospital stay.
Table 4 - Patient demography:
Study Group 
(Tight Glycaemic 
Control)
Control Group 
(Normal 
Glycaemic 
Control
p value
Number of patients 25 25
Age  (years) 51.6 ± 8.6 54 ± 7.1 0.402
Male: Female 13: 12 9: 16
Weight (kg) 66.7 ± 11.3 65.8 ± 10.2 0.491
 Duration of diabetes 
(years)
6.4 6.16 0.667
HbA1c (%) 8.38 ± 0.96 8.5 ± 1.5 0.089
Pre-operative glucose 143.9± 36.1 146.8 ± 36.7 0.587
Type of surgery
Intra-abdominal
Superficial
Cardio-Vascular
7
15
3
4
17
4
Table 5: Blood Glucose levels
Study Group 
(Tight Glycaemic 
Control)
n=25
Control Group 
(Normal 
Glycaemic 
Control)
n=25
p value
Preoperative glucose 143.9 ± 36.15 146.8 ± 36.7 0.587
Intra-operative glucose 126.0 ± 25.3 139 ±  31.9 0.08
Post-operative 
Day 1  136.0 ± 17.1 220 ± 48.3 0.000 *
Day 2 134.9 ± 16.1 209 ± 36.1 0.000 *
Day 3 139.1 ± 26.7 194 ± 35.2 0.000 *
Day 4 160.2 ± 48.0 185 ± 32.7 0.027 *
Day 5 145.2 ± 36.8 160 ± 31.7 0.049 *
Day 6 171.9 ± 53.8 160.2 ± 46.0 0.719
Day 7 166.3 ± 57.8 157 ±  45.8 0.696
Table 6: Post-operative morbidity and mortality
Study Group 
(Tight Glycaemic 
Control)
n=25
Control Group 
(Normal Glycaemic 
Control)
n=25
p value
Infections 1 (4%) 11 (44%)
Surgical site 
infection
1 (4%) 7   (28%) 0.02 *
Respiratory 
infections
0 5   (20%) 0.018 *
Urinary tract 
infections
0 1   (4%) 0.312
Hypoglycaemia 3 (12%) 1 (4%) 0.29
Death 1 (4%) 0 0.312
Hospital stay (days) 8.0 ± 3.4 10.5 ± 5.6 0.212
      Table 7: Comparison between patients with and without wound infection 
With wound 
infection
Without wound 
infection
p 
value
Number of Patients         8 42
Age       55.6 ± 8.7 52.6 ± 8.0 0.719
Weight        71 ± 12.6 64.9 ± 10.1 0.312
Pre-operative glucose 
(mg.dL-1)
     157.5 ± 36 143 ± 36.0 0.194
Intra-operative glucose 
(mg.dL-1)
     166.8 ± 35.7 126.5 ± 23.3 0.001*
Post-operative glucose (mg.dL-1)
Day 1 210 ± 39.5 171 ± 56.6 0.039*
Day 2 206.5 ± 36.5 165 ± 45.7 0.012*
Day 3 199.3 ± 39.9 160 ± 39.2 0.018*
Day 4 195.5 ± 44.17 167 ± 41.0 0.100
Day 5 164.8 ± 55.4 150 ± 27 0.645
Surgery duration (minutes) 226.8 ± 89 215 ± 135.8 0.412
HbA1C (%) 8.55 ± 0.9 8.52 ± 1.3 0.364
Hospital stay (days) 13.3 ± 4.1 8.52 ± 4.5 0.010
Duration of Diabetes (years) 8.87 ± 7.0 6.0 ± 4.0 0.244
                                              DISCUSSION
It  is  widely  accepted  that  patients  with  diabetes  are  at  higher  risk  of  developing 
infections and other post-operative complications. This is attributed to the short-term 
effect  of  hyperglycaemia  on  the  immune  function,  pathogen  growth  and  vascular 
permeability and also its long-term effect on microvasculature and tissue proteins.(1) 
The  usual  line  of  management  of  diabetic  patient  is  directed  towards the glycaemic 
control  which  can  be  acutely  brought  under  control  by  intensive  insulin  therapy. 
However, it is a well established fact that chronic exposure to high glucose level leads to 
glycosylation of proteins and collagen leading to poor wound healing.(41) The level of 
glycosylated  haemoglobin  (HbA1c)  may  be  taken  as  a  surrogate  measure  of  the 
glycosylation  of  the  tissues.  Although,  the  American  Diabetes  Association  has 
recommended  a  HbA1c  <  7%  as  a  measure  of  good  diabetic  control,  (10)  this 
investigation is frequently not measured or ignored.
The purpose of this study was an attempt to answer two questions -
a) Do diabetics with HbA1c greater than 7 % have a higher incidence of post-operative 
infection?
b) In diabetics with HbA1c > 7 %, can a tighter glycaemic control in the peri-operative 
period decrease the incidence of post-operative infection?
To  answer  the  first  question,  a  prospective  clinical  audit  was  done  on  all  diabetic 
patients undergoing major surgery, over a six month period. Those with HbA1c >7 % 
had a significantly higher incidence of surgical site infection. The previous studies (46, 
47, 6) which have addressed this issue could not demonstrate this correlation, perhaps 
due to the fact that they segregated the patients at a higher level of HbA1c (11.5% and 
8%). The American Diabetes Association considers good glycaemic control with HbA1c 
<7 %, and hence it was the criteria chosen for this study. However, the peri-operative 
blood glucose showed wide fluctuations, perhaps a reflection of uncontrolled diabetes. 
Similar findings have being demonstrated in a recently published retrospective audit (9), 
but the difference in the incidence of wound infection between the two groups was not 
significant.
This  clinical  audit  formed  the  basis  of  the  investigative  clinical  trial  to  answer  the 
second question.  The standard protocol,  in  this  institution,  to  manage post-operative 
diabetic patients in the general ward is to monitor the blood glucose, using Accuchek®, 
every 4-6 hours and to administer insulin subcutaneously if the blood glucose exceeds 
200 mg.dL-1. This is a trade-off between preventing the glucose to exceed the widely 
accepted  level  for  increased  post-operative  complications  (1)  and  the  dreaded 
complication of hypoglycaemia in a poorly supervised, general ward.
In the study group, the aim was to maintain the blood glucose < 140 mg.dL-1. Although, 
various  recommendations  exist,  a  meta-analysis  of  14  studies  has  shown that  blood 
glucose >140 mg.dL-1 with or without a prior diagnosis of diabetes increased both in-
hospital mortality and congestive heart failure.(2) A tighter control of blood glucose in 
the  post-operative  period  would  have  required  more  frequent  monitoring  to  detect 
hypoglycaemia.  This  would  raise  the  issues  of  finances,  the  feasibility  in  a  poorly 
supervised, busy general ward and the morbidity of an undetected hypoglycaemic event.
The pre-operative and intra-operative blood glucose levels were comparable between the 
two  groups,  but  the  mean  blood  glucose  over  the  five  post-operative  days  was 
significantly lower in the study group. The incidence of surgical site and respiratory 
infection  (44%)  was  significantly  higher  in  the  control  group,  which  reflected  in 
prolonged hospital stay. 
In most clinical settings, the peri-operative management of diabetics is based on the pre-
operative blood glucose levels. However, the clinical audit has shown (Table 1) that 
even  with  good  pre-operative  and  the  intra-operative  glycaemic  control,  the  rate  of 
surgical site infection is higher among those with HbA1c >7 %. This would suggest that 
acute  hyperglycaemia  can  be  controlled  but  the  residual  effects  of  chronic 
hyperglycaemia may linger on. A significant finding in the audit as well as the clinical 
trial was that the mean glucose level during the first three post-operative days in those 
who developed wound infection was above 200 mg.dL-1. Therefore, it seems that the 
effect  of  chronic  hyperglycaemia may  be offset  by tight  glycaemic  control  over  the 
initial  3-5  days  after  surgery.  This  study  has  tried  to  answer  the  commonly  faced 
dilemma among physicians managing diabetic patients with reasonably well-controlled 
blood glucose but raised glycosylated haemoglobin.
Limitations of the study
The sample size of 36 for the ‘clinical trial’ was based on the clinical audit, wherein the 
incidence of surgical site infection was 30%. The duration of the clinical trial was for 
one year, and the number of diabetics with HbA1c > 7 % scheduled for elective surgery 
was only 50. Therefore, the study findings of these 50 patients (25 in each group) were 
analysed, which has shown statistical significance. 
Conclusion
Diabetics  with  glycosylated  haemoglobin  more  than  7  % have  a  high  incidence  of 
surgical site infection and other complications in the post-operative period which can be 
reduced by maintaining a mean glucose level below 140 mg.dL-1 during the initial 3 – 5 
post-operative days.
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                                                                       PROFORMA
NAME                                                                   AGE/SEX                            WEIGHT
HOSPITAL.NO.                                                  DATE OF SURGERY
 DIAGNOSI
 TYPE OF SURGERY                                         
                                                                             DATE OF ADMISSION
DURATION OF SURGERY
DURATION OF DIABETES 
TREATMENT OF DIABETES                                              OHA/ INSULIN
ASSOCIATED DISEASES
OTHER DRUGS
TYPE OF ANAESTHESIA
PRE- OP BLOOD GLUCOSE Fasting - 
Post-prandial - 
                                                                                       
HbA1C
PRE-Induction 
(On the day of surgery)
ANTIBIOTICS:
PRE-OPERATIVE                                    Yes / No
POST-OPERATIVE Yes / No
DURATION OF HOSPITAL STAY -  
          INTRA-OPERATIVE
Glucose Insulin
Ist HOUR
IInd HOUR
IIIrd HOUR
IVth HOUR
Maintain intraop blood glucose < 140mg.dL-1 
 POST-OPERATIVE 
COMPLICATIONS Day1 Day2 Day3 Day4 Day5 Day6 Day7
Wound Infection
Wound Dehiscence
Postoperative Blood Glucose
Post operative ICU stay
Wound re-exploration
Hypoglycemic episodes
Metabolic derangements
Cardiovascular events :
Infections:
UTI/RTI
                                        PATIENT INFORMATION
Person who are diabetic have been shown to be more prone to complications after their 
surgery such as wound infection, longer hospital stay etc.This has usually been 
attributed to high blood sugar during and after the surgery .Hence we check blood sugar 
at frequent interval and take measures to correct it
There has been concern that long term control of sugar, may also contribute to these 
complications. Glycosylated hemoglobin reflects the control of sugar over the previous 
2-4 months. This study is an attempt to look into this aspect. We want to see if the 
complications are less in patients with high Glycosylated hemoglobin, if the blood sugar 
is maintained lower than what is usually maintained after surgery i.e., around 140mg 
instead of less than 200mg.If you volunteer for this study, we would be taking a blood 
sample to check your Glycosylated hemoglobin if not done with in the last one month.
However volunteering for this study is optional and the care that you receive in this 
hospital will not be affected by your decision
                                        INFORMED CONSENT
  
I have been explained in detail about the study by dr. ----------------
I am willing to volunteer at my own free will and am aware that I can withdraw at any 
time, without it affecting my medical care in this hospital.
Doctors name:                                                                                                  signature:
Signature:
S/NO. H.NO AGE 
GROU
P SEX
WEIG
HT TYPSX SXD DODM
OT 
PROB
TY OF 
AN PRE SUG
1
989987
C 68 1 1 57 1 630 3 1 1
2
449257
B 54 1 1 56 2 360 20 5 1
3
980435
C 55 1 2 65 0 135 10 1 1
4
873300
A 55 1 2 64 3 150 3 1
5
998428
C 68 1 2 65 4 120 2 1 1
6
949625
C 64 1 1 65 5 180 2 1 1
7
645498
B 65 1 1 65 3 390 7 1 1
8
507116
C 46 1 1 60 0 150 3 1 1
9
971043
C 40 1 1 75 0 120 1 1 1
10
643909
A 59 1 1 60 2 420 18 5 1
11
036840
D 42 1 1 83 5 120 5 1
12
012776
D 50 1 1 66 0 660 5 1
13
016223
D 57 1 1 92 3 120 10 1 2
14
440373
A 48 1 2 85 3 120 10 1 2
15
022011
D 43 1 1 45 0 300 5 1 3
16
017611
D 46 1 1 60 0 240 5 3
17
929580
C 42 1 2 56 4 150 2 1
18
154185
A 45 1 2 63 4 120 10 1 1
19
055135
D 50 1 2 75 4 180 2 1
20
045528
D 46 1 1 68 3 120 9 1 1
21
669143
C 57 1 2 72 3 180 1 1
22
072117
D 48 1 2 68 3 120 5 1 2
23
820200
C 38 1 2 90 3 150 8 3 2
24
060622
D 48 1 2 60 3 120 10 1 1
25
072317
D 56 1 1 56 6 180 6 1 1
26
917291
A 63 2 2 57 3 120 5 5 1
27
008780
D 38 2 2 83 3 240 1 1 2
28
988788
C 42 2 2 50 5 150 3 1
29
988038
C 58 2 1 50 2 390 15 5 1
30
004960
D 64 2 1 68 8 120 22 4 1
31
585833
C 47 2 1 75 5 240 10 1
32
986249
C 56 2 2 58 7 195 5 1 2
33
991035
C 66 2 2 66 2 360 15 5 1
34
004238
D 52 2 2 68 4 150 4 1 1
35
986450
C 54 2 1 67 0 120 1 1 1
36
052822
C 47 2 1 70 8 360 7 1
37
752086
B 52 2 1 65 7 90 4 1
38
567128
B 66 2 1 66 5 240 10 1 1
39
016919
D 65 2 1 69 5 120 1 4 1
40
043602
D 52 2 2 65 4 135 3 1
41
023079
C 44 2 1 65 3 180 3 3
42
952849
C 48 2 1 59 9 240 1 1 1
43
976633
B 51 2 1 55 0 300 1 2
44
003650
D 51 2 2 78 4 135 8 2
45 636106
A
54 2 1 51 0 420 3 2
46
969865
C 56 2 1 63 2 330 10 5 2
47
780420
C 62 2 2 65 3 135 3 1 2
48
447403
C 55 2 1 60 0 270 6 1
49
013265
D 47 2 2 60 3 120 3 1 1
50
984626
C 60 2 1 95 7 120 10 5 2
D2 D3 D4 D5 D6 D7 HBA1C
PRE 
ANT
POST 
ANT
WD 
INF
HOS 
STAY
DEAT
H
127 110 129 98 133 145 8.5 0 1 0 10
165 170 265 177 204 149 7.2 0 1 0 9
151 168 165 154 144 142 8.2 0 1 0 9
143 129 135 139 135 8 0 0 0 7
124 184 173 159 8.3 0 0 0 9
147 156 135 128 133 7.8 0 0 0 7
137 129 135 113 116 98 7.8 0 1 0 9
155 135 121 118 131 130 8.4 0 1 0 10
128 7.5 0 1 0 3
168 189 223 121 165 156 7.4 0 1 0 10
138 121 114 8.7 0 0 0 5
119 124 114 175 262 261 7.7 0 0 0 19
134 170 218 138 7.7 0 0 0 8
140 132 142 129 7.4 0 0 0 10
116 109 210 155 241 250 9 0 0 0 15
107 114 136 123 7.7 0 0 0 7
123 10.6 0 0 0 3
131 122 11.1 0 0 0 5
144 115 255 263 256 8.8 0 0 1 7
121 108 116 9.8 0 0 0 7
137 136 117 130 143 8.4 0 0 0 6
107 132 9 0 0 0 7
136 191 195 170 8.5 0 0 0 7
154 120 123 126 7.7 0 0 0 6
122 136 145 8.5 0 0 0 5
185 212 166 152 122 7 0 0 0 12
173 180 175 90 88 99 10.7 0 0 1 14
267 239 181 153 158 110 9.5 0 1 0 9
206 212 213 225 211 225 7.8 0 1 0 17
208 205 215 188 217 193 8 0 0 1 16
238 191 182 165 183 208 12.5 0 1 0 15
193 189 134 134 97 8.1 1 0 1 15
216 229 227 146 129 137 8.1 0 1 1 15
246 176 160 131 8 0 0 0 7
212 196 187 170 12 0 0 0 6
188 178 7.5 0 1 0 5
263 8.8 0 0 0 3
247 224 8.7 0 0 0 4
178 7.1 0 0 0 3
221 157 158 154 130 113 7.2 0 0 0 9
169 177 213 154 7.5 0 1 0 6
183 134 209 194 136 7.5 0 1 0 8
249 100 188 177 208 146 8.8 0 0 0 16
167 160 144 184 10.8 0 0 0 6
129 183 239 125 157 203 7.2 0 0 0 25
215 220 239 220 248 8.5 0 1 1 18
165 238 212 179 8.4 0 0 0 8
247 212 154 133 150 142 8.7 1 1 1 15
210 220 134 156 169 7.1 0 0 0 6
256 245 165 145 7.5 0 0 1 7
                                                        GLOSSARY
TYPSX                                                               TYPE OF SURGERY
SXD                                                                   SURGERY DURATION
DODM                                                            DURATION OF DIABETES
OT PROB                                                       OTHER PROBLEMS
TY OF AN                                                      TYPE OF ANAESTHESIA
PRE SUG                                                         PRE OPERATIVE SUGARS
INT SUG                                                           INTRA OPERATIVE SUGARS
POST D1                                                          POST OPERATIVE DAY 1
POST D2                                                                                          DAY 2
D3                                                                                          DAY 3
D4                                                                                          DAY 4
D5                                                                                           DAY 5
D6                                                                                            DAY 6
D7                                                                                            DAY 7
HBA1C                                                           GLYCOSYLATED HAEMOGLOBIN
PRE ANT                                                        PRE OPERATIVE ANTIBIOTIC
POST ANT                                                       POST OPERATIVE ANTIBIOTIC
WD INF                                                            WOUND INFECTION
HOS STAY                                                            HOSPITAL STAY
HYPOG                                                                  HYPOGLYCAEMIA
UTI                                                                         URINARY TRACT INFECTION
RTI                                                                                   RESPIRATORY TRACT  
INFECTION
